PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
---|---|---|---|---|---|---|---|
30866136 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | viremia | NA | NA | NA | unclassified | |
impact of human leukocyte antigen and calculated panel reactive antibody on bk viremia in kidney transplant recipients: a single-center experience and literature review. | |||||||
30866136 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | viremia | NA | NA | NA | unclassified | |
the aim of this retrospective analysis was to investigate the effect of human leukocyte antigen (hla) and calculated panel reactive antibody (cpra) on bk virus activation as evidenced by bk viremia (bkv). | |||||||
31622220 | HLA-B*51 | viremia | Colombian | NA | NA | unclassified | |
in addition, the magnitude of the polyfunctional response induced by the hla-b*51-restricted qrplvtiri autologous epitope correlated with low viremia. | |||||||
32004619 | HLA (HLA) | rs2255336 | NA | rs3820998 | rs11614913 | positive | |
NA | |||||||
33812439 | HLA (HLA) | viremia | NA | NA | NA | unclassified | |
hla haplotype, pretreatment including atg, and cmv viremia, and agvhd are the independent risk factors for hc after allo-hsct. | |||||||
34355738 | HLA (HLA) | viremia | NA | NA | NA | unclassified | |
low reservoir was independently associated with treatment precocity, protective hla, and low cumulative viremia since cart initiation. | |||||||
9435427 | HLA-DR (HLA-DR) | thyroid-associated ophthalmopathy | NA | NA | NA | unclassified | |
we used flow cytometry to investigate the effects of nicotinamide, an inhibitor of poly (adp ribose) synthetase, on the cell-surface expression of cytokine-induced human leukocyte antigen (hla)-a,b,c antigen, hla-dr antigen, intercellular adhesion molecule 1, cd44, and fas expression in cultured orbital fibroblasts from patients with thyroid-associated ophthalmopathy. | |||||||
23209462 | MICA*00 | thyroid-associated ophthalmopathy | Korean | NA | NA | positive+negation | |
patients who did not have thyroid-associated ophthalmopathy showed higher frequencies of mica*010 (or = 2.99; 95% ci, 1.47-6.08, p < 0.003, p(c) < 0.042) and lower frequencies of mica*008 (or = 0.08; 95% ci, 0.01-0.62, p < 0.001, p(c) < 0.014) compared to those of controls. | |||||||
23209462 | MICA*01 | thyroid-associated ophthalmopathy | Korean | NA | NA | positive+negation | |
patients who did not have thyroid-associated ophthalmopathy showed higher frequencies of mica*010 (or = 2.99; 95% ci, 1.47-6.08, p < 0.003, p(c) < 0.042) and lower frequencies of mica*008 (or = 0.08; 95% ci, 0.01-0.62, p < 0.001, p(c) < 0.014) compared to those of controls. | |||||||
7549026 | HLA-DQA1 (HLA-DQA1) | gastrointestinal diseases | NA | NA | NA | negation | |
gliadin antibodies are also found in other gastrointestinal diseases, other disorders and in healthy individuals not carrying the coeliac disease-specific dqa/dqb alleles. |
Copyright 2024